We Announce role as Strategic Advisor to Gener8 on its Acquisition of Symbient

Alira Health’s Strategy Consulting and Transaction Advisory practices collaborate to help Gener8 grow beyond its core business.

News
Published on:
March 11, 2020

MUNICH, GERMANY – MARCH 11, 2020 – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, was selected as the strategic advisor to Gener8, a Sunnyvale, California-based engineering and manufacturing firm serving the life sciences and medical device industries, in their acquisition of Symbient Product Development, LLC, a leading provider of design engineering for polymer life sciences consumables, based in Carlsbad, California. Gener8 is a portfolio company of Sverica Capital Management LP.

“The team at Symbient has built a tremendous business, taking on high complexity engineering projects with best-in-class turnaround times,” said David Brakenwagen, Gener8 CEO. “We are already collaborating on a number of customer programs which are yielding great success and are excited to provide this differentiated end market solution with the decades of combined technology, know-how and experience.”

“We are proud to support Gener8 in a transaction that allows them to offer customers a complete turnkey instrument and consumable solution,” says Dr. Michal Raciborski, Partner, Alira Health. “Our Strategy Consulting practice performed a comprehensive commercial due diligence on Symbient and its major markets to support Gener8’s evaluation of the transaction’s commercial value proposition and related opportunities and risks. Our team is dedicated to identifying and executing on these types of synergistic opportunities that deliver long-term profitability and value for our clients.”

“Congratulations to Gener8 and Symbient on a transaction that will bring even greater innovation to the product development and contract manufacturing markets. We have unique expertise in the CDMO space with transaction and market knowledge and direct contact with major players and potential targets around the world,” says Carlo Stimamiglio, Partner, Alira Health. “Our strong track record in M&A and strategy consulting assignments makes Alira Health the ideal choice for clients who need support on the definition and implementation of their growth strategies.”

About Gener8:

Gener8, founded in 2002, offers full product lifecycle engineering and manufacturing for highly complex instruments and products within the highly regulated Life Sciences and Medical Device markets. The services that Gener8 provides allow for an agile and fast time to market solution that results in high reliability solutions for customers. With locations in Sunnyvale, CA and Boston, MA Gener8 operates in the corridors of innovation and maintains all industry specific certifications.

For more information, please visit www.gener8.net.

Related news

MedTech
News July 22, 2021
Alira Health Welcomes Fredrik Nyberg as Partner and Regional Head
We are pleased to announce that Fredrik Nyberg has joined Alira Health as Partner and Regional Head
Due Diligence Pharma
News July 21, 2021
Alira Health Announces its Role as Strategic Advisor to Naxicap
Alira Health is proud to announce its role as strategic advisor to Naxicap in the equity investment in Ceres Pharma Bv.
MedTech
Events July 15, 2021
Event: Cardio Wearables 2021 Conference
Join Piergiulio Lauriano for an exclusive discussion on Cardio Wearables Investments and M&A Trends during the conference.
MedTech Pharma
Events June 30, 2021
Event: Bio Asia-Taiwan
Join Daniela Sica, Vice President, Business Development, Pharma & Biotech, and Shu-Ling Cheng, Partner, at Biotechnology Innovation Organization's Bio-Asia Taiwan July 21-25, 2021.
MedTech
Publications June 2, 2021
Infographic: U.S. Go-to- Market Strategy Design for Wearable Technology in Healthcare
When our client, a European healthcare-based startup developing wrist wearables wanted to expand to the U.S., the Alira Health team helped develop a go-to-market strategy for this new segment.
MedTech
Publications May 14, 2021
Pocket Guide To MedTech’s Market Outlook In 2021
In this article Carlo unveils findings and summaries from The 2021 MedTech Contract Manufacturing Report, recently published by Alira Health in collaboration with Life Science Intelligence(...)
MedTech
Publications May 7, 2021
Robotic Surgery Report Pre-download
Want to learn more about key topics and trends across robotic surgery and commercial considerations? Be the first to have access to our upcoming report on Robotics, written by Alira(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.